Vol. 49 No. 8 (2010): Acta Oncologica

Articles

• Rectal cancer radiotherapy: Towards European consensus

  Vincenzo Valentini, Bengt Glimelius

  1206-1216

  Published: 2010-11-01

  • PDF

• Relative biological effectiveness of photon energies used in brachytherapy and intraoperative radiotherapy techniques for two breast cancer cell lines

  Anne B. L. Marthinsen, Ragnhild Gisetstad, Signe Danielsen, Jomar Frengen, Trond Strickert, Steinar Lundgren

  1261-1268

  Published: 2010-11-01

  • PDF

• Population TCP estimators in case of heterogeneous irradiation: A new discussion of an old problem

  Pavel Stavrev, Colleen Schinkel, Nadia Stavreva, Brad Warkentin, Marco Carlone, B. Gino Fallone

  1293-1303

  Published: 2010-11-01

  • PDF

• A review of in vitro experimental evidence for the effect of spatial and temporal modulation of radiation dose on response

  Natalka Suchowerska, Martin A. Ebert, David R. McKenzie, Michael Jackson

  1344-1353

  Published: 2010-11-01

  • PDF

• Atypical metastatic profile in Stewart-Treves syndrome

  Mark H. Almond, Robin L. Jones, Khin Thway, Cyril Fisher, Eleanor Moskovic, Ian R. Judson

  1388-1390

  Published: 2010-11-01

  • PDF

• The interface of population-based cancer registries and biobanks in etiological and clinical research – current and future perspectives

  Kristin Andersson, Freddie Bray, Marc Arbyn, Hans Storm, Roberto Zanetti, Göran Hallmans, Jan W. Coebergh, Joakim Dillner

  1227-1234

  Published: 2010-11-01

  • PDF

• Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer

  Maria Andersen, Katrine R. Schønnemann, Mette Yilmaz, Helle A. Jensen, Lene W. Vestermark, Per Pfeiffer

  1246-1252

  Published: 2010-11-01

  • PDF

• Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival

  Birgitte V. Offersen, Marianne M. Knap, Michael R. Horsman, Jan Verheijen, Roeland Hanemaaijer, Jens Overgaard

  1283-1287

  Published: 2010-11-01

  • PDF

• Analytical investigation of the possibility of parameter invariant TCP-based radiation therapy plan ranking

  Nadejda Stavreva, Alan Nahum, Krassimir Markov, Ruggero Ruggieri, Pavel Stavrev

  1324-1333

  Published: 2010-11-01

  • PDF

• Dose-painting IMRT optimization using biological parameters

  Yusung Kim, Wolfgang A. Tomé

  1374-1384

  Published: 2010-11-01

  • PDF

• Useful genetic variation databases for oncologists investigating the genetic basis of variable treatment response and survival in cancer

  Sevtap Savas

  1217-1226

  Published: 2010-11-01

  • PDF

• When tumor repopulation starts? The onset time of prostate cancer during radiation therapy

  Mingcheng Gao, Nina A. Mayr, Zhibin Huang, Hualin Zhang, Jian Z. Wang

  1269-1275

  Published: 2010-11-01

  • PDF

• Severe hypofractionation: Non-homogeneous tumour dose delivery can counteract tumour hypoxia

  Ruggero Ruggieri, Stefania Naccarato, Alan E. Nahum

  1304-1314

  Published: 2010-11-01

  • PDF

• Computer simulation of tumour control probabilities after irradiation for varying intrinsic radio-sensitivity using a single cell based model

  Christine Harting, Peter Peschke, Christian P. Karger

  1354-1362

  Published: 2010-11-01

  • PDF

• Changes in resting energy expenditure (REE) as a function of tumor response to sunitinib in a cachexic patient with a metastatic endocrine tumor of the pancreas

  Yasmina Zoheir, Catherine Leroux, Denis Picot, Eveline Boucher, Odile Audrain, Jean-Luc Raoul

  1390-1391

  Published: 2010-11-01

  • PDF

• TCP modelling – why is it important?

  Marco Carlone, Alan Nahum, Pavel Stavrev

  1205

  Published: 2010-11-01

  • PDF

• Do we need fractionation-corrected doses in sequential two-phase treatments? A quantification of dose differences between non-corrected and corrected combined non-uniform dose distributions in normal tissue

  Caroline Olsson, Karl-Axel Johansson

  1253-1260

  Published: 2010-11-01

  • PDF

• Hypofractionated Adjuvant Whole Breast Radiotherapy: Progress and Prospects

  John Yarnold, Joanne Haviland

  1288-1292

  Published: 2010-11-01

  • PDF

• A mathematical framework for separating the direct and bystander components of cellular radiation response

  Martin A. Ebert, Natalka Suchowerska, Michael A. Jackson, David R. McKenzie

  1334-1343

  Published: 2010-11-01

  • PDF

• Clinical heterogeneity and tumor control probability

  Avraham Eisbruch

  1385-1387

  Published: 2010-11-01

  • PDF

• Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression

  Kevin Yi-Lwern Yap, Yasmin Xiu Xiu Ho, Wai Keung Chui, Alexandre Chan

  1235-1245

  Published: 2010-11-01

  • PDF

• Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden

  Lars Norberg, Robert Johansson, Torgny Rasmuson

  1276-1282

  Published: 2010-11-01

  • PDF

• From cell population models to tumor control probability: Including cell cycle effects

  Thomas Hillen, Gerda de Vries, Jiafen Gong, Chris Finlay

  1315-1323

  Published: 2010-11-01

  • PDF

• Datamining approaches for modeling tumor control probability

  Issam El Naqa, Joseph O. Deasy, Yi Mu, Ellen Huang, Andrew J. Hope, Patricia E. Lindsay, Aditya Apte, James Alaly, Jeffrey D. Bradley

  1363-1373

  Published: 2010-11-01

  • PDF